Obiectiv: Costurile în creştere în domeniul îngrijirii sănătăţii sunt de interes tot mai mare şi un factor major care afectează costurile de spitalizare sunt complicaţiile postoperatorii. Complicaţiile după Intervenţiile Chirurgicale Abdominale Majore (ICAM) sunt asociate cu o morbiditate şi mortalitate crescută. În acest studiu sunt estimate costurile îngrijirilor postoperatorii asociate cu complicaţiile. Metodă: Noi am efectuat un studiu retrospectiv pe 254 de pacienţi internaţi în Clinica I de Chirurgie Generală şi Oncologică a Institutului Oncologic din Bucureşti, care au suferit ICAM. Au fost analizate costurile totale de spitalizare, complicaţiile şi tratamentul efectuat. Rezultate: Pentru un pacient care a suferit ICAM, costurile medii pentru intervenţia chirurgicală, fără complicaţii, sunt de 5.791,3 lei şi ajung la o medie de 20.806 lei după complicaţii majore. Concluzie: Rezultatele oferă o perspectivă asupra costurilor de spitalizare la pacienţii oncologici operaţi. Complicaţiile apar la 20,86% dintre pacienţii care au suferit ICAM şi reprezintă 50% dintre costurile totale de îngrijire. Stabilirea şi aplicarea unui protocol care vizează diagnosticarea şi tratamentul precoce al complicaţiilor specifice ar putea duce la o scădere a morbidităţii şi a mortalităţii, dar şi al costurilor de spitalizare.
Introduction
Rising costs in health care are of progressively growing interest and a major factor affecting hospitalization costs is represented by postoperative complications. Major abdominal and pelvic surgery (MAPS) can be defined as surgical oncological interventions performed in the genital area (uterine, cervical, ovarian tumours) and abdominal area (gastric, hepatobilio-pancreatic, colorectal tumours). Digestive surgery involves anastomoses and / or stomas.
Complications arising from major abdominal surgery (genital and digestive) may be associated with a morbidity between 3.7 and 35%, and mortality is increased (1.4-12.3%). Data from the literature show that postoperatively complications may occur in a percentage between 12.3% and 20% (1, 2, 3) . Complications require intensive care and close monitoring of patients. Increased morbidity and mortality imply an increase in the number of days spent in ICU (anaesthesia and intensive care unit) and in the total days of hospitalization, resulting in an increase of over 50% in hospital costs (1) .
Material and Method
The classification of postoperative complications was done in according with the one proposed by Dindo-Clavien, which divides complications into minor and major (4, 5) . Grade I and II minor complications require non-invasive treatment, while for grade III and IV major complications invasive treatment under local or general anaesthesia (surgical reintervention, CT guided drainage etc.) and / or readmission and monitoring in ICU are required, which also generated an increase in hospital resources requirement (sanitary materials, medication, additional paraclinical and imaging investigations etc.). Our study estimates the costs of postoperative care associated with complications.
We performed a retrospective study, conducted between August 2015 and December 2016, on 254 patients who underwent major abdominal and pelvic surgery (MAPS). The analysis was carried out in the 1 st General and Oncological Surgery Clinic of "Al. Trestioreanu" Oncology Institute in Bucharest. Costs of complications were tracked for patients who exceeded the average hospital stay, namely 14 days for digestive interventions (more than 5 days in the ICU) and 9 days for patients requiring surgery for genital neoplasms (more than 1 day in the ICU). Expenses for hospitalization, food, medication, sanitary materials, laboratory tests and imaging investigations were analysed. The costs of surgical reinterventions were not separately analysed.
Apart from the basic blood tests, C-reactive protein (CRP) and leucocytosis in the peritoneal drainage fluid were evaluated in patients with digestive interventions on days 1, 3 and 5 postoperatively. Peritoneal leukocyte count was performed by centrifugation in the urinalysis machine. The data obtained were correlated with the leukocyte count and haemoglobin value progression on the CBC. In patients with genital tumours, leukocyte count and haemoglobin value progression were monitored.
Clinical data collected from the patient (fever, dynamic ileus, intestinal occlusion, vomiting, increase in naso-gastric fluid volume and changes in appearance, peritoneal irritation signs, hepato-renal failure, tachyarrhythmias etc.) were correlated with paraclinical and imaging investigations.
All patients received antibiotics (cephalosporins) and pre-and postoperative thrombo-prophylaxis. Major complications (grades III-V according to Dindo-Clavien) required invasive treatment, ICU monitoring, and also increased hospital stay. These complications led to the allocation of additional budgetary resources within the hospital, also affecting the costs of the Surgery Clinic.
Results
The following tumour localizations were taken under supervision:
• (Table 1) .
Of the 134 patients submitted to pelvic surgery, 9 (6.71%) had major complications, accounting for 16.98% of the total complications. The 9 patients accounted for 3.5% of the total patients and accounted for 29.03% of major postoperative complications (Table 1) .
Patients operated on at the level of the digestive tract were in a number 120. Of these, 22 (18.33%) had major complications representing 83.02% of the total complications. The 22 patients constituted 8.66% of the investigated patients and represented 70.96% of the major postoperative complications.
The postoperative mortality recorded for the entire group of 254 patients during hospitalization was of 6 patients, representing 2.36% (0.39% -genital and 1.96% -digestive respectively). Compared to the group with major complications, deaths represented 19.35% (3.22% genital and 16.12% digestive) ( Table 1 ). Other clinics (1, 3) report major postoperative complications ranging from 15% to 24%, and mortality between 14% -15.3%. In our lot, major complications were recorded in 12.30% of cases, and mortality in those with major complications was 19.35%. In the patients included in the study (254), 11 reinterventions (4.33%) were required out of the entire group, 7 for patients submitted to surgery on the digestive tract (5.83%) and 4 for genital area interventions in women (2.98%). All these reinterventions required prolonged treatment in the ICU (13.57 days on average), increased hospital stay to an average of 24.28 days, and higher hospitalization costs: 21.046 RON on average per reintervention (Tables 2, 3 and 4) .
Of the 254 patients, 53 patients had various complications representing 20.86%. 31 patients (12.20%) experienced major complications. Costs of treatment for an oncological patient were on average (Table 4) . severity that exceeds that of the complications after gynaecological interventions. Diagnosis and treatment of these severe complications remain a challenge and are important in reducing morbidity and mortality. The occurrence of postoperative complications involved an increase in the number of laboratory tests, the introduction of additional investigations (CRP, leukocyte count from the peritoneal drainage fluid), additional imaging investigations (X-rays, ultrasound exam, CT), prolonged conservative treatment and / or surgical reinterventions, all leading to prolonged ICU and hospital stay. Thus, our study shows how postoperative complications, especially major ones (classified by DindoClavien), can significantly increase patient treatment costs.
In our patients, complications occurred in 20.86% of cases, out of which major ones represented about 12.20%, a percentage similar to that reported by other clinics with similar pathology (1). Compared to major complications, deaths were 19.35% (3.22% genital and 16.12% digestive). Other clinics (1,3) report major postoperative complications ranging from 15% to 24%, and mortality between 14% -15.3%.
The occurrence of these complications led to an average increase of costs from 5,791.3 RON to 20,806 RON, 3.5 times higher compared to uncomplicated patients. A major impact of the costs of patients with major complications on the hospital budget was observed. It should be noted that patients who present a major postoperative complication may require continued outpatient treatment and / or home care, and in some of them present delays in returning to work, which can involve additional costs for society.
With regard to this, the study also aimed to search / associate laboratory and imaging investigations that would allow the discovery of specific complications and their early treatment. This could translate into fewer days of hospitalization (both in the ICU and on the ward postoperatively) and, therefore, lower hospital costs. The data obtained by us, as well as those in the literature, show that CRP may foreshadow the occurrence of a complication long before its clinical and imaging manifestation (1.5 days versus 4 days), allowing early diagnosis and aggressive treatment (6) . For new digestive sutures we also introduced leukocyte count monitoring from peritoneal drainage fluid, along with CRP and CBC. Major abdominal and pelvic surgery sometimes involves extensive interventions, sometimes with multiple organ resections. These interventions predispose to incidents and intraoperative accidents, which can contribute to increased hospitalization costs (7) .
Abdominal and pelvic surgical interventions for cancer require the administration of an injectable anticoagulant to prevent deep vein thrombosis (DVT) and its complications (thromboembolism). Data from the literature show that the incidence of thromboembolism was 4.89% in patients followed for 90 days postoperatively. Occurrence of DVT in patients undergoing major abdominal surgery resulted in a 1.5-fold increase in hospitalization duration and a 2.8-fold increase in total costs at 90 days postoperatively, compared to patients who did not develop this complication. Thus, effective prophylactic treatment of DVT is recommended to reduce the economic burden associated with major abdominal surgery. (8) In terms of gynaecological interventions for cancer, the percentage of patients with major complications is 3 times lower than that observed in patients who underwent surgery at the level of the digestive tract (6.71% versus 18.33%). On the other hand, complications following gynaecological surgery are of considerably smaller size and lower severity than those of digestive surgery. Good management of fast postoperative recovery, with the prevention and timely treatment of possible complications, is associated with low morbidity and a substantial reduction in hospitalization costs. (9, 10) Thoraco-abdominal X-ray and abdominopelvic ultrasound were the most used imaging investigations. CT was performed at the indication of a specialist (anaesthesia and intensive care specialist, surgeon, neurologist etc.), without the possibility of treatment of abdomino-pelvic septic complications through percutaneous drainage. Any surgeon's dream is surgery without complications. Our endeavours and efforts are directed accordingly. All efforts are being made to achieve this goal. However, there are a number of variables that interfere with the patient's postoperative evolution, making complications possible: vascular field, preexisting septic factors, nutrition status, neoplasia, radio-chemotherapy, the magnitude of the surgical intervention, and others.
Conclusions
Postoperative complications in abdominal and pelvic oncological surgery occur in approximately 20.86% of patients and represent approximately 54% of the costs of patients undergoing these surgeries. Major complications were present in a percentage of 12.20%, relative to the entire studied group, and increased patient costs by 3.5 times. Severe complications require emergency emplyment of exploration means needed to obtain early diagnosis and initiate prompt treatment.
We consider that the introduction into the diagnostic protocol of complications of CRP (C-Reactive Protein) and of leukocyte count from the peritoneal fluid, together with CBC, are useful for early diagnosis of postoperative complications. Abdomino-pelvic ultrasound and thoraco-abdominal radiography, which are cost-effective, could also contribute to these.
In the future, we are trying to introduce CRP determination and leukocyte count from the peritoneal fluid as a standard for early postoperative diagnosis of specific complications. CT scanning remains the most valuable method providing topographical data regarding the site of the complication, indicating the approach pathway: interventional CT or classic / laparoscopic surgical approach.
General postoperative complications do not fall into the surgeon's field of work, their diagnosis and resolution being in their entirety the responsibility of the intensive care physician. These complications may precede or may develop concurrently with complications specific to the surgical intervention.
The results we obtained provide an insight into the cost of hospitalization in oncological patients undergoing surgery. Establishing and applying a protocol aimed at early diagnosis and treatment of specific complications could lead to a decrease in morbidity, mortality, as well as in hospitalization costs.
